TUESDAY, Oct. 29, 2024 -- Genome sequencing of newborns is both feasible and acceptable for parents...
Author - David Miller
Clinical Practice Guideline Updated for Migraine, Tension-Type...
TUESDAY, Oct. 29, 2024 -- In a clinical practice guideline (CPG) issued by the U.S. Department of...
ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone...
TUESDAY, Oct. 29, 2024 -- For patients with asthma, inhaled corticosteroids (ICS) combined with...
UroGen Submits Completed UGN-102 NDA Seeking Approval as the...
PRINCETON, N.J.–(BUSINESS WIRE)–Aug. 14, 2024– UroGen Pharma Ltd. (Nasdaq: URGN)...
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in...
TUESDAY, Oct. 29, 2024 -- Among privately insured patients, there was a doubling in the use of...
USPSTF Recommends Screening for Domestic Violence in Pregnant...
TUESDAY, Oct. 29, 2024 -- The U.S. Preventive Services Task Force recommends screening for intimate...
Clinicians Often Fail to Rescue Women With Complications After...
TUESDAY, Oct. 29, 2024 -- Clinicians fail to rescue female patients with complications after...
FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug...
MADISON, New Jersey, September 23, 2024 – LEO Pharma Inc. announced today that the Food and Drug...
Many Seniors at Risk for Financial Precarity From Cost of...
TUESDAY, Oct. 29, 2024 -- Many Medicare beneficiaries are at risk for financial hardship from the...
Iterum Therapeutics Provides Update on FDA Advisory Committee...
DUBLIN and CHICAGO, Sept. 10, 2024 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)...